News

Yu Galaxy Announces Launch of Fund III

📄 Download Press Kit

Q&A with PR Yu, Founder & Managing Partner at Yu Galaxy

PR Yu is Founder & Managing Partner of Yu Galaxy, a leading solo-GP venture firm. A graduate of Peking University (0.01% acceptance) and a full-scholarship Ph.D. at CU Boulder, he began as a scientist developing new solar technologies before founding his own company to commercialize them for maximum social impact.
Read More

How A High-Tech Chair Could Revolutionize Cancer Radiation Therapy

Startup Leo Cancer Care is transforming proton radiation treatment with a simple idea: having patients sit up instead of lying down. Now hospitals that include Stanford and McLaren are lining up to buy dozens of machines.
Read More

Yu Galaxy Secures $90M Raise to Surpass $500M AUM, Redefining How Venture Capital Invests in Global Challenges

As one of America’s largest solo GP-led firms, Yu Galaxy reaches a remarkable milestone — showing how a lean, mission-driven model can deliver outsized impact in healthcare, AI, defense, and automation.
Read More

Getting personal

PR Yu, founder of Yu Galaxy, talks about his unique infrared therapy device, the kind of legacy he wants to leave and the convergence of the digital and physical worlds. Ryan Hibbison reports
Read More

Capstan Medical Secures $110M to Bring First-of-its-Kind Robotics Technology to Heart Disease Patients

Led by Eclipse, the round will further allow the company to bring the benefits of robotics to one of the few remaining untouched areas of medicine and structural heart
Read More

Inquis Medical Announces $40 Million Series B Financing to Accelerate Advancement of Aventus Thrombectomy System Addressing Venus Thromboembolic Diseases

MENLO PARK, Calif.--(BUSINESS WIRE)--Inquis Medical, a pioneering medical technology company specializing in advanced thrombectomy systems, today announced the successful closure of its $40 million Series B financing round.
Read More

Be bolder: What leaders can learn from CU Boulder’s successes in research, innovation, and football

Recognize that it’s never too late to rebuild and revive your organization. If a public university of almost 150 years of history could do it, why can’t yours?
Read More

Transforming Medicine: Aqtual Secures $16M Series A to Pioneer Precision Treatment Solutions Copy

Aqtual secures $16M Series A to revolutionize precision medicine, offering hope for personalized treatments in diseases like rheumatoid arthritis and cancer.
Read More

Breaking Barriers: Elve's $15M Series A Funding Propels Wireless Revolution

Elve's $15M Series A funding marks a milestone in revolutionizing wireless internet access worldwide. Proud to support their groundbreaking work! 🚀
Read More